CoreRx

CoreRx is a Contract Development and Manufacturing Organisation (CDMO) that delivers comprehensive product development and manufacturing solutions tailored to the pharmaceutical industry. Founded in 2006, CoreRx is dedicated to offering innovative formulation and analytical development, clinical manufacturing, and commercial supply of a diverse range of dosage forms, including solid oral, liquid oral, and topical preparations. The company's collaboration with sister company Bend Bioscience enhances its capabilities, particularly in bioavailability enhancement, solid dosage form development, and the stabilization of biologics and vaccines. Together, they are committed to improving patients' lives by ensuring timely product delivery without compromising science or quality.

Services include:
- Analytical Services
- Contract Development and Manufacturing (CDMO)
- Contract Manufacturing (CMO)
- Dosage Form Development
- Drug Development
- Encapsulation
- Fluid Bed Processing
- Process Development
- Formulation Development
- Controlled Release
- Granulation
- Chromatography
- Manufacturing
- Capsule
- Controlled Substances
- Creams & Ointments
- Dose Form
- Non-Sterile
- Liquids
- Oral Drug Delivery
- Orally Dispersible Tablet
- Powders
- Semisolids
- Solid Dosage
- Solutions & Suspensions
- Suppositories
- Sustained Release
- Syringe
- Pre-filled
- Tablets
- Topicals
- Microdosing
- Packaging
- Blister
- Clinical Trials
- Particle Size Analysis
- Preclinical Testing
- Preformulation
- Quality QA/QC
- R&D Services
- Scale-Up
- Stability Studies
- Stability
- ICH
- Aseptic Fill-Finish
- Tablet Coating
- UV-VIS Spectrophotometer Analysis
- Validation
- Clinical

CoreRx continues to set industry standards in the pharmaceutical sector, leveraging its extensive expertise to deliver high-quality products. For more information, visit corerxpharma.com.